Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability Enhancement: Drug Permeability Enhancement
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Fischer Projections
Structure-Activity Relationships and Drug Design
Anticoagulant Drugs: Low-Molecular-Weight Heparins
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 12, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Sonia Ziada1, Abdennour Braka1,2, Julien Diharce1
1Institut de Chimie Organique et Analytique (ICOA), UMR7311 CNRS-Université d'Orléans , Université d'Orléans, Orléans Cedex 2, France.
This chapter details enhanced molecular dynamics methods, umbrella sampling (US) and accelerated molecular dynamics (aMD), for studying protein dynamics. It provides practical guidance on their application in drug design and computational research.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: